Literature DB >> 33667174

Use of a Telemedicine Risk Assessment Tool to Predict the Risk of Hospitalization of 496 Outpatients With COVID-19: Retrospective Analysis.

James B O'Keefe1, Elizabeth J Tong1, Thomas H Taylor2, Ghazala A Datoo O'Keefe3, David C Tong4.   

Abstract

BACKGROUND: Risk assessment of patients with acute COVID-19 in a telemedicine context is not well described. In settings of large numbers of patients, a risk assessment tool may guide resource allocation not only for patient care but also for maximum health care and public health benefit.
OBJECTIVE: The goal of this study was to determine whether a COVID-19 telemedicine risk assessment tool accurately predicts hospitalizations.
METHODS: We conducted a retrospective study of a COVID-19 telemedicine home monitoring program serving health care workers and the community in Atlanta, Georgia, with enrollment from March 24 to May 26, 2020; the final call range was from March 27 to June 19, 2020. All patients were assessed by medical providers using an institutional COVID-19 risk assessment tool designating patients as Tier 1 (low risk for hospitalization), Tier 2 (intermediate risk for hospitalization), or Tier 3 (high risk for hospitalization). Patients were followed with regular telephone calls to an endpoint of improvement or hospitalization. Using survival analysis by Cox regression with days to hospitalization as the metric, we analyzed the performance of the risk tiers and explored individual patient factors associated with risk of hospitalization.
RESULTS: Providers using the risk assessment rubric assigned 496 outpatients to tiers: Tier 1, 237 out of 496 (47.8%); Tier 2, 185 out of 496 (37.3%); and Tier 3, 74 out of 496 (14.9%). Subsequent hospitalizations numbered 3 out of 237 (1.3%) for Tier 1, 15 out of 185 (8.1%) for Tier 2, and 17 out of 74 (23%) for Tier 3. From a Cox regression model with age of 60 years or older, gender, and reported obesity as covariates, the adjusted hazard ratios for hospitalization using Tier 1 as reference were 3.74 (95% CI 1.06-13.27; P=.04) for Tier 2 and 10.87 (95% CI 3.09-38.27; P<.001) for Tier 3.
CONCLUSIONS: A telemedicine risk assessment tool prospectively applied to an outpatient population with COVID-19 identified populations with low, intermediate, and high risk of hospitalization. ©James B O'Keefe, Elizabeth J Tong, Thomas H Taylor Jr, Ghazala A Datoo O’Keefe, David C Tong. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 30.04.2021.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; nonhospitalized; outcomes; outpatient; risk assessment; telemedicine

Year:  2021        PMID: 33667174     DOI: 10.2196/25075

Source DB:  PubMed          Journal:  JMIR Public Health Surveill        ISSN: 2369-2960


  6 in total

1.  Efficacy of Telemedicine and At-Home Telemonitoring following Hospital Discharge in Patients with COVID-19.

Authors:  Roi Suárez-Gil; Emilio Casariego-Vales; Rosa Blanco-López; Fernando Santos-Guerra; Cristina Pedrosa-Fraga; Álvaro Fernández-Rial; Iria Íñiguez-Vázquez; María Mar Abad-García; Mercedes Bal-Alvaredo
Journal:  J Pers Med       Date:  2022-04-10

2.  Description of symptom course in a telemedicine monitoring clinic for acute symptomatic COVID-19: a retrospective cohort study.

Authors:  James B O'Keefe; Elizabeth J Tong; Ghazala D O'Keefe; David C Tong
Journal:  BMJ Open       Date:  2021-03-05       Impact factor: 2.692

3.  Postacute Sequelae of SARS-CoV-2 Infection and Impact on Quality of Life 1-6 Months After Illness and Association With Initial Symptom Severity.

Authors:  James B O'Keefe; H Caroline Minton; Mary Morrow; Colin Johnson; Miranda A Moore; Ghazala A D O'Keefe; Karima Benameur; Jason Higdon; Jessica K Fairley
Journal:  Open Forum Infect Dis       Date:  2021-07-27       Impact factor: 3.835

4.  Wearable sensor derived decompensation index for continuous remote monitoring of COVID-19 diagnosed patients.

Authors:  Dylan M Richards; MacKenzie J Tweardy; Steven R Steinhubl; David W Chestek; Terry L Vanden Hoek; Karen A Larimer; Stephan W Wegerich
Journal:  NPJ Digit Med       Date:  2021-11-08

5.  Effectiveness of a monitored home isolation program for COVID-19 infection during the second wave of the pandemic.

Authors:  Kundavaram Paul Prabhakar Abhilash; Ranjit Immanuel James; Hema Eunice Paul; Malathi Murugesan; Deepak Thomas Abraham; Jeyalinda Christopher; Annie Valsan; Joy John Mammen; Priscilla Rupali; Ilavarasi Jesudoss; Senthamil Selvan; Prasad Mathews; John Victor Peter
Journal:  Med J Armed Forces India       Date:  2022-09-02

6.  Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review.

Authors:  Cecilia Vindrola-Padros; Kelly E Singh; Manbinder S Sidhu; Theo Georghiou; Chris Sherlaw-Johnson; Sonila M Tomini; Matthew Inada-Kim; Karen Kirkham; Allison Streetly; Nathan Cohen; Naomi J Fulop
Journal:  EClinicalMedicine       Date:  2021-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.